SENSEX    73088.33       599.34    |    NIFTY    22147       151.15 FAQ    |    Feedback
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Lupin, Tata Chemicals, Divgi TorqTransfer, Surya Roshni to be watched
14-Mar-23   08:51 Hrs IST

Lupin: Global pharma major Lupin announced that the United States Food and Drug Administration (USFDA) has completed an inspection of its Bioresearch Centre in Pune. The inspection closed without any observation.

Tata Chemicals: Fitch Ratings revised the outlook on the company's Long-Term Foreign-Currency Issuer Default Rating (IDR) to Positive from Stable and affirmed the rating at 'BB+.

GAIL (India). The company has declared interim dividend for FY 2022-23 of 40% on the paid-up equity share capital, which is Rs 4 per equity share, with a record date of 21 March 2023.

Divgi TorqTransfer Systems: Shares of the auto component maker will debut on the bourses today, 14 March 2023. The issue price is Rs 590 per share. The IPO was subscribed 5.44 times.

Krsnaa Diagnostics: The company has operationalized 100 more pathology collection centers to provide services of Lab Investigation Facilities under Hinduhridaysamrat Balasaheb Thakeray Chikitsa for BMC Dispensaries and Hospitals in Mumbai. With this, the company has operationalized 300 pathology collection centers.

B.L. Kashyap and Sons: The company has secured new orders from domestic unrelated clients aggregating to Rs. 158 crores approx., excluding GST.

Surya Roshni: The company received orders amounting to Rs. 96.39 crores (including GST) for supply of 3LPE coated Line pipes from HPCL for City Gas Distribution projects in three geographical areas in the state of Rajasthan, Bihar, Jharkhand and West Bengal.

CreditAccess Grameen: The country's largest Non-Banking Financial Company-Micro Finance Institution (NBFC-MFI) crossed a milestone of Rs 20,000 crore Assets under Management (AUM). The AUM of the company as on 31 December 2022 was Rs 17,786 crore.

Powered by Capital Market - Live News

Europe (EUR) 1.00 0.86 89.09 1.07
United Kingdom (GBP) 1.17 1.00 104.07 1.25
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.80 83.55 1.00
Market News << ALL News
  20-Apr-2024, (11:02 )  CRISIL upgrades rati..
  20-Apr-2024, (08:47 )  IREDA Q4 PAT climbs ..
  19-Apr-2024, (05:24 )  HDFC AMC Q4 PAT clim..
  19-Apr-2024, (04:41 )  Wipro Q4 PAT rises 5..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)